The Association Between the p53/ topoisomerase I and p53/ topoisomerase IIα Immunophenotypes and the Progression of Ovarian Carcinomas
Journal Title: Advances in Clinical and Experimental Medicine - Year 2012, Vol 21, Issue 1
Abstract
[b]Background.[/b] In in vitro studies it has been revealed that p53 protein expression might regulate topoisomerase I (topo I) and topoisomerase IIα (topo IIα) levels in tumor cells. So far, the association between the p53 protein and topo I and topo IIα expression and its impact on ovarian carcinoma progression has not been analyzed. [b]Objectives.[/b] The aim of the study was to examine the association between topo I and topo IIα expression and p53 protein overexpression with respect to the morphological features and progressive growth of ovarian tumors. [b]Material and Methods.[/b] The expression of the studied biomarkers was estimated by immunohistochemical staining in tumor sections from 136 malignant and 30 benign ovarian neoplasms. [b]Results. [/b]Significant differences for topo I, topo IIα and p53 expression between malignant and benign tumors were observed (p < 0.01). The expression of topo IIα and p53 protein was associated with advanced stages of ovarian carcinomas (p < 0.01). Differences between topo I-positive cases and low (G1) and high (G3) tumor grade had only borderline significance (p = 0.07). In ovarian carcinomas, positive correlations between topo I and topo IIα, topo I and p53 and topo IIα and p53 protein expression were revealed (p = 0.001). No relationship between the studied biomarkers was found in benign ovarian tumors (p > 0.05). p53/topo I and p53/topo IIα immunophenotypes were associated with advanced stages of ovarian carcinoma (p = 0.045 and p = 0.009, respectively). p53/topo IIα positive ovarian carcinomas were more frequently observed in high than in low tumor grades and the differences were only of borderline significance (p = 0.07). [b]Conclusions.[/b] Current findings suggest that on the one hand, cooperation between topo I, topo IIα and p53 protein participates in the progressive growth of ovarian tumors. On the other hand, simultaneous expression of the studied proteins identifies the subgroup of ovarian cancers with aggressive biological features which might be considered in therapy.
Authors and Affiliations
Julia Bar, Piotr Grelewski, Leszek Noga, Jerzy Rabczyński, Marian Gryboś, Michał Jeleń
Keywords
Related Articles
- EP ID EP103413
- DOI -
- Views 99
- Downloads 0
Inability to Have Children Caused by Recurrent HELLP Syndrome in Early Pregnancies – Implications for a Review of Literature
This review is inspired by a case of two pregnancies of the same patient complicated by HELLP syndrome, which suggests that there is a predisposition for the occurrence of preeclampsia and HELLP syndrome in early pregnan...
Niedobory oraz nadmierna aktywacja układu dopełniacza człowieka w chorobach o różnorodnej etiologii
Układ dopełniacza jest integralnym elementem odporności chroniącym organizm gospodarza przed wnikaniem i rozprzestrzenianiem różnorodnych drobnoustrojów. Bierze również udział w usuwaniu uszkodzonych i zmienionych komóre...
Obrazowanie w chorobie zwyrodnieniowej kręgosłupa – obecny stan wiedzy
Autorzy przedstawiają obecne poglądy na temat obrazowania choroby zwyrodnieniowej kręgosłupa (ch.zw.kr.), która jest jedną z najczęstszych schorzeń u ludzi. W pierwszej części pracy omówiono najważniejsze definicje oraz...
Pelvi-caliceal Collecting System in Swine – Authors Own Anatomical Classification
[b]Background[/b]. Experiments on humans and their organs produce legal, moral and ethical dilemmas. Nowadays, the use of domestic swine as an experimental animal is increasing steadily. Thus it is important to know the...
The Association Between the p53/ topoisomerase I and p53/ topoisomerase IIα Immunophenotypes and the Progression of Ovarian Carcinomas
[b]Background.[/b] In in vitro studies it has been revealed that p53 protein expression might regulate topoisomerase I (topo I) and topoisomerase IIα (topo IIα) levels in tumor cells. So far, the association between the...